# Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response

> **NCT06822491** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Zurich** · enrollment: 28 (estimated)

## Conditions studied

- Prostate Carcinoma
- Localized Prostate Adenocarcinoma
- Stereotactic Body Radiotherapy
- Stereotactic Radiotherapy
- Magnetic Resonance Imaging
- Multiparametric MRI

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06822491
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-20
- **Primary completion:** 2026-06
- **Final completion:** 2031-06
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822491, "Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06822491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*